Connect your AI

Mannkind MNKD Developed Technology On Body Infusor Intangible Assets

Developed Technology On Body Infusor Intangible Assets at other companies

Crane NXT, Inc.CXT

$45.5M0.0%

The RealRealREAL

$13.94M-25.4%

Nano Nuclear EnergyNNE

$3.71M+319%

Rumble, Inc.RUM

$716.55K—

Tarsus Pharmaceuticals, Inc.TARS

$7.96M-63.4%

Lantheus HoldingsLNTH

$6.19M-79.2%

Other financials

Income statement

Revenue$90.2M+15.1%

Gross profit$82.7M+10.8%

Operating income-$1.7M-107%

Net income-$16.6M-226%

EPS (diluted)-$0.05-225%

Balance sheet

Cash & equivalents$52.8M+11.7%

Total debt$12.2M-9.4%

Total equity-$59.2M-1.0%

Total assets$744.4M+81.5%

Cash flow

Operating cash flow-$5.4M+15.9%

CapEx$1.9M+470%

Free cash flow-$7.2M-8.0%

Valuation

Market cap$1.19B+3.5%

Enterprise value$1.15B+3.0%

P/E228.5×—

P/S3.3×-0.6×

Profitability

Gross margin91.5%-2.6pp

Operating margin23.3%+3.1pp

Net margin9.3%—

FCF margin13.8%—

Returns & leverage

Return on equity-8.8%—

Debt / equity-0.2×—

Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept mnkd:DevelopedTechnologyOnBodyInfusorIntangibleAssets.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's developed technology on body infusor intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Mannkind's developed technology on body infusor intangible assets?: Mannkind (MNKD) reported developed technology on body infusor intangible assets of $185.71M in Q1 2026.
What does developed technology on body infusor intangible assets mean?: This represents the capitalized value of developed technology assets related to on-body infusion delivery systems. It reflects the company's investment in proprietary drug delivery hardware that has reached commercial or near-commercial readiness. This asset is subject to amortization and impairment testing over its useful life.